Krishna Institute of Medical Sciences Limited Earnings Summary — Q4 FY2026

• Revenue grew significantly by 21.6% YoY to ₹7,203 million, driven by expansion and increased medical service volumes.
• Net profit was negatively impacted by a ₹74 million one-time exceptional charge related to the implementation of the New Labour Codes.
• The company is in a heavy CAPEX phase, with Property, Plant, and Equipment (PPE) nearly doubling YoY to ₹41,862 million.
• Borrowings have risen sharply to ₹26,726 million (non-current) to fund aggressive greenfield and brownfield hospital projects.
• Profitability is currently under pressure from higher finance costs (₹681 million vs ₹202 million YoY) and increased depreciation.
• Management has strengthened the leadership team with the appointment of a new CFO and re-designation of an Executive Director.

Management is focused on integrating recent acquisitions and scaling the cluster-based model into Tier-2 and Tier-3 cities to provide affordable super-specialty care.

Deteriorating

While revenue growth remains robust, the rapid escalation in debt and interest costs is compressing net margins and return ratios in the short term.

KIMS is transitioning from a regional cash-surplus entity to a multi-state hospital group. The outlook depends on the successful stabilization of occupancy in new units to offset the high fixed costs and interest burden.